Drug Details: HYPAQUE-CYSTO

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Drug Details

Drug Name:	HYPAQUE-CYSTO
FDA Application No:	(NDA) 016403
Active Ingredient(s):	DIATRIZOATE MEGLUMINE
Company:	GE HEALTHCARE
Original Approval or Tentative Approval Date:	August 21, 1969
Chemical Type:	3 New dosage form
Review Classification:	P Priority review drug

Therapeutic Equivalents	Labels are not available
Approval History, Letters, Reviews and Related Documents

You can see the products in the same application. The table can be sorted by clicking the header columns.

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code
HYPAQUE	DIATRIZOATE MEGLUMINE	60%	INJECTABLE; INJECTION	Prescription	Yes	AP
HYPAQUE	DIATRIZOATE MEGLUMINE	30%	INJECTABLE; INJECTION	Discontinued	No	None
HYPAQUE-CYSTO	DIATRIZOATE MEGLUMINE	30%	SOLUTION; URETHRAL	Prescription	No	AT

Comments for HYPAQUE-CYSTO

Name: *

Email: *

Text:
(HTML OK)

Enter the code from the picture: *
(click here to load another image)

There are no comments.